COVID-19: the epidemiology and treatment
- PMID: 33135928
- DOI: 10.12968/hmed.2020.0580
COVID-19: the epidemiology and treatment
Abstract
After initially emerging in late 2019, coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread rapidly to cause a global pandemic. SARS-CoV-2 is a betacoronavirus that is closely related to severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus, all of which can cause severe lung injury, respiratory distress and cytokine storm. While mortality rates associated with SARS-CoV-2 are lower than those associated with severe acute respiratory syndrome coronavirus or Middle East respiratory syndrome coronavirus, it is more contagious and spreads more rapidly than these other viruses. This article summarises the epidemiology and potential options for treating COVID-19 to give a foundation for future studies of the diagnosis, treatment and prevention of this deadly disease.
Keywords: Antivirals; COVID-19; Immunomodulators; SARS-CoV-2; Vaccines.
Similar articles
-
The coronavirus pandemic: can we handle such epidemics better?J R Soc Med. 2020 May;113(5):171-175. doi: 10.1177/0141076820924587. J R Soc Med. 2020. PMID: 32407647 Free PMC article. No abstract available.
-
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.J Infect Public Health. 2020 Nov;13(11):1601-1610. doi: 10.1016/j.jiph.2020.07.011. Epub 2020 Aug 4. J Infect Public Health. 2020. PMID: 32778421 Free PMC article.
-
The novel zoonotic COVID-19 pandemic: An expected global health concern.J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671. J Infect Dev Ctries. 2020. PMID: 32235085
-
Infectious Disease Transmission Models to Predict, Evaluate, and Improve Understanding of COVID-19 Trajectory and Interventions.Ann Am Thorac Soc. 2020 Oct;17(10):1204-1206. doi: 10.1513/AnnalsATS.202005-501PS. Ann Am Thorac Soc. 2020. PMID: 32610024 Free PMC article. No abstract available.
-
The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment.Int J Environ Res Public Health. 2020 Mar 30;17(7):2323. doi: 10.3390/ijerph17072323. Int J Environ Res Public Health. 2020. PMID: 32235575 Free PMC article. Review.
Cited by
-
Quality of life in postmenopausal women with osteoporosis: a systematic review and meta-analysis.Qual Life Res. 2023 Jun;32(6):1551-1565. doi: 10.1007/s11136-022-03281-1. Epub 2022 Nov 16. Qual Life Res. 2023. PMID: 36383282
-
Pain in Osteoporosis: Current and Future Strategies.Drugs Aging. 2025 Jul 9. doi: 10.1007/s40266-025-01225-1. Online ahead of print. Drugs Aging. 2025. PMID: 40634658 Review.
-
Oxygen efficient respiratory Aid (OxEraTM) device: A safety study.Afr J Emerg Med. 2022 Sep;12(3):172-176. doi: 10.1016/j.afjem.2022.03.003. Epub 2022 May 20. Afr J Emerg Med. 2022. PMID: 35611145 Free PMC article.
-
The influence of high doses of vitamin C on functional recovery and postoperative pain in patients with trochanteric fracture after intramedullary nailing during a three-month follow-up: a full-scale study.Eur J Orthop Surg Traumatol. 2025 May 13;35(1):189. doi: 10.1007/s00590-025-04332-2. Eur J Orthop Surg Traumatol. 2025. PMID: 40355782 Clinical Trial.
-
Efficacy of Sofosbuvir plus Ledipasvir in Egyptian patients with COVID-19 compared to standard treatment: a randomized controlled trial.J Med Life. 2022 Mar;15(3):350-358. doi: 10.25122/jml-2021-0175. J Med Life. 2022. PMID: 35449996 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous